JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

Inflammatory breast cancer (IBC) is a difficult-to-treat disease with poor clinical outcomes due to high risk of metastasis and resistance to treatment. In breast cancer, CD44(+)CD24(−) cells possess stem cell-like features and contribute to disease progression, and we previously described a CD44(+)...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Laura E., Peluffo, Guillermo, Qiu, Xintao, Temko, Daniel, Fassl, Anne, Li, Zheqi, Trinh, Anne, Seehawer, Marco, Jovanović, Bojana, Alečković, Maša, Wilde, Callahan M., Geck, Renee C., Shu, Shaokun, Kingston, Natalie L., Harper, Nicholas W., Almendro, Vanessa, Pyke, Alanna L., Egri, Shawn B., Papanastasiou, Malvina, Clement, Kendell, Zhou, Ningxuan, Walker, Sarah, Salas, Jacqueline, Park, So Yeon, Frank, David A., Meissner, Alexander, Jaffe, Jacob D., Sicinski, Piotr, Toker, Alex, Michor, Franziska, Long, Henry W., Overmoyer, Beth A., Polyak, Kornelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Tumor Biology and Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845989/
https://www.ncbi.nlm.nih.gov/pubmed/36409824
http://dx.doi.org/10.1158/0008-5472.CAN-22-0423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845989/
https://www.ncbi.nlm.nih.gov/pubmed/36409824
http://dx.doi.org/10.1158/0008-5472.CAN-22-0423

Ejemplares similares